Skip to content

The CAG Bipolar the CAG Bipolar RCT

Effects of Specialized Treatment for Bipolar Disorder - the CAG Bipolar RCT

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04229875
Enrollment
1000
Registered
2020-01-18
Start date
2020-01-13
Completion date
2025-01-13
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Brief summary

The CAG Bipolar study is a large-scale pragmatic randomized controlled trial aiming to investigate whether specialized and more centralized treatment (into a clinical academic group (CAG)) improves lives and outcomes for patients with bipolar disorder (N= 1000 patients).

Detailed description

Bipolar disorder is a complex illness with a complex treatment that differs during manic, depressed and remitted states, frequently leaving patients with decreased quality of life and impaired psychosocial function. Traditionally, psychiatry has been sparsely subspecialized in Denmark as well as internationally during the last four decades leaving patients in generalized psychiatric settings. At the same time, demands to clinical skills, research and education have increased, and IT solutions have emerged as a possible way to optimize treatment. Effects of organizational changes and digital health interventions are rarely investigated scientifically in health care services. This is a randomized controlled trial conducted in the entire Mental Health Services, Capital Region of Denmark including all psychiatric centers in the region. The CAG Bipolar study is a large-scale pragmatic randomized controlled trial aiming to investigate whether specialized and more centralized treatment (into a clinical academic group (CAG)) improves lives and outcomes for patients with bipolar disorder (N= 1000 patients). Findings from the study will have great impact on future organization and optimization of treatment within psychiatry in Denmark as well as internationally.

Interventions

OTHERCAG Bipolar

See description of CAG Bipolar

Sponsors

Maria Faurholt-Jepsen, MD, DMSc
CollaboratorUNKNOWN
The Mental Health Services in the Capital Region of Denmark
CollaboratorUNKNOWN
Mental Health Services in the Capital Region, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with a main diagnosis of bipolar disorder in the five largest psychiatric centers in the Mental Health Services, Capital Region of Denmark (Psychiatric Center Copenhagen, Psychiatric Center Hillerød, Psychiatric Center Amager, Psychiatric Center Glostrup and Psychiatric Center Ballerup) will be asked for participation

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Risk of psychiatric hospitalizationDuring the entire study period of 12 months pr participantData on hospitalization according to data from the population-based Danish Psychiatric Central Research Register will be collected and analyzed with survival statistics. Assessed blinded for the intervention status
Cumulated duration of hospitalization according to data from the population-based Danish Psychiatric Central Research RegisterDuring the entire study period of 12 months pr participantData on cumulated duration of hospitalization according to data from the population-based Danish Psychiatric Central Research Register will be collected and analyzed with survival statistics. Assessed blinded for the intervention status

Secondary

MeasureTime frameDescription
Satisfaction with care according to scores on the Verona Satisfaction Scale-Affective DisorderBaseline, 6 months and 12 monthsPatient evaluated. Higher scores indicate higher satisfaction with treatment.
Satisfaction with care according to scores on the Danish nation-wide patient satisfaction questionnaireBaseline, 6 months and 12 monthsPatient evaluated. Higher scores indicate higher satisfaction with treatment.
Adherence to the Danish national guidelines of medical treatment of bipolar disorder according to use of the three main maintenance mood stabilizers for bipolar disorder: lithium, lamotrigine or quetiapineDuring the entire study period of 12 months per participantData collected from electronic patient records.
Clinicians' satisfaction with their work at start and end of the RCTBaseline and 12 monthsClinician evaluated using the Medical Personnel Job Satisfaction Questionnaire
Patient-reported depressive symptoms according to the major depressive Inventory (MDI)Baseline, 6 months and 12 monthsPatient-evaluated. Higher scores indicate higher level of depressive symptoms.
Patient-reported manic symptoms according to the Altman Self-rating Scale for Mania (ASRM)Baseline, 6 months and 12 monthsPatient-evaluated. Higher scores indicate higher level of manic symptoms.
Proportion of patients starting group-based psychoeducationDuring the entire study period of 12 months per centreProportion of patients in clinics starting in group-based psychoeducation
Quality of life according to WHO Quality of Life-BREF (WHOQoL)Baseline, 6 months and 12 monthsScored between 0-100. Higher scores indicate higher quality of life. Patient evaluated
Perceived stress according to Cohen's Perceived stress scaleBaseline, 6 months and 12 monthsPatient evaluated. Scores between 0-40. Higher score indicate higher perceived stress.

Other

MeasureTime frameDescription
Long-term register-based outcome measures: psychosocial measures (sickdays)3, 5 and 10 years follow-upDanish registry data with data available on number of days away form work
Long-term register-based outcome measures: somatic comorbidity3, 5 and 10 years follow-upDanish registry data with data available on somatic diagnoses
Long-term register-based outcome measures: rate of suicide and death3, 5 and 10 years follow-upDanish registry data with the data available
Long-term register-based outcome measures: prescribed medication3, 5 and 10 years follow-upDanish registry data with data available on the medicine prescribed
Long-term register-based outcome measures: duration of hospitalization3, 5 and 10 years follow-upDanish registry data with data available on number of longt-term days during hospitalizations
Long-term register-based outcome measures: risk of hospitalization3, 5 and 10 years follow-upDanish registry data with data available on number of longt-term hospitalizations

Countries

Denmark

Contacts

Primary ContactLars Vedel Kessing, Prof., MD, DMSc
lars.vedel.kessing@regionh.dk+4538647073
Backup ContactMaria Faurholt-Jepsen, MD, DMSc
maria.faurholtjepsen@regionh.dk+4538647073

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026